Megan Daly, Md
Clinical trials sponsored by Megan Daly, Md, explained in plain language.
-
New combo attack on inoperable lung cancer
Disease control CompletedThis early-stage study tested a new combination treatment for patients with early-stage lung cancer who could not have surgery. It combined a targeted, high-dose radiation treatment with a drug (atezolizumab) designed to help the immune system fight cancer. The main goal was to f…
Phase: PHASE1 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Vaccine-Immunotherapy combo tested in Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether combining a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) could help control advanced non-small cell lung cancer in patients whose previous treatments had stopped working. The vaccine aims to train the immune system to recognize and atta…
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC